
NYSE pre-market update highlights new cancer drug collaboration and Oracle's AI solutions launch
The New York Stock Exchange (NYSE) pre-market update on September 29, 2026, featured key developments including Envisagenics partnering with Boehringer Ingelheim to develop precision therapies for hard-to-treat cancers. Oracle introduced Fusion Claw,...



